Flowable Hemostats Market

Flowable Hemostats Market Size, Share & Trends Analysis Report and Forecast 2021-2027
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2024219 | Category : Medical Devices | Delivery Format: /

The global market for flowable hemostats is expected to grow at a significant CAGR during the forecast period (2021-2027). Flowable hemostats are made of a bovine or porcine gelatin matrix and have a thick yet flowable consistency. It is also possible to use topical thrombin in the hemostats asthey come in handy while working on difficult-to-reach surfaces or in a damp field. Other than eye surgery, flowable hemostats can be utilized for any surgical operation. Surgiflo (Johnson & Johnson) is a porcine gelatin-based product that may be used with thrombin. Bovine gelatin matrix and human pooled plasma thrombin are included in FloSeal (Baxter).

The rise in the incidence of bleeding disorders has opened the path for flowable hemostats to be designed, developed, and tested. In hospitals, surgical bleeding can result in long-term bleeding problems. To combat this, hemostat products including gelatin-based collagens, fibrin sealants, and active thrombin preparations are used to limit the quantity of delayed blood flow from the body. Prolonged bleeding, if not treated, can raise the risk of infection, death, and hemodynamic instability. Flowable hemostats, which have a thick consistency and contain bovine matrix, are the most widely utilized among the many types of hemostats.

The global flowable hemostats market is being driven by an increase in global trauma and accident cases. Every year, an estimated 1.25 million people die in road traffic accidents throughout the globe, according to the World Health Organization (WHO). Furthermore, according to a study conducted by the US Armed Forces in 2013, 25% of battlefield fatalities are medically preventable. Uncontrolled blood loss is responsible for over 90% of these fatalities. As a large number of mortalities were caused due to over bleeding,  governments have been compelled to design and implement improved bleeding control measures. The number of patients suffering from trauma and various chronic diseases is continuously increasing across the globe. As a result, the number of surgical operations is expected to rise, driving the global flowable hemostats market growth.

Manufacturers are boosting the availability of clinically validated flowable hemostats to meet their growing demand. For instance, Teleflex Inc., a global producer of medical technology, is promoting its clinically-proven D-Stat Flowable Hemostat, which helps to minimize the formation of hematomas in pulse generator implants.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Material – Porcine Gelatin, Bovine Gelatin

o By Application – General Surgery, Cardiac Surgery, Vascular Surgery, Neuro & Spine Surgery, Orthopedic Surgery

o By Product – Active Hemostats, Passive Hemostats, Combination Hemostats

o By End – User – Hospitals, Clinics, Diagnostic Laboratories, Ambulatory Surgery Centers

    • Competitive Landscape: Baxter International, Stryker Corporation, Cryolife, Inc., Becton, Dickson & Company, Medtronic Ltd., Johnson & Johnson Services and Pfizer Inc. among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Flowable Hemostats Market Report 

By Material

    • Porcine Gelatin

    • Bovine Gelatin

By Application

    • General Surgery

    • Cardiac Surgery

    • Vascular Surgery

    • Neuro & Spine Surgery

    • Orthopedic Surgery

By Product

    • Active Hemostats

    • Passive Hemostats

    • Combination Hemostats

By End – User

    • Hospitals

    • Clinics

    • Diagnostic Laboratories

    • Ambulatory Surgery Centers

By Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa